Last reviewed · How we verify
NCT06223243
The Effect of Stingless Bee Honey Mouthrinse on Dental Plaque Accumulation
NA trial testing Stingless bee honey mouthrinse in Plaque Accumulation in 30 participants. Completed in 1 January 2024.
1 September 2023
Quick facts
| Lead sponsor | Universiti Sains Islam Malaysia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 30 |
| Start date | 1 March 2023 |
| Primary completion | 1 September 2023 |
| Estimated completion | 1 January 2024 |
| Sites | 1 location across Malaysia |
Drugs / interventions tested
- Stingless bee honey mouthrinse
- normal saline mouthrinse
- chlorhexidine mouthrinse — full drug profile →
Conditions studied
- Plaque Accumulation — all drugs for Plaque Accumulation →
- Patient Acceptance — all drugs for Patient Acceptance →
Sponsor
Universiti Sains Islam Malaysia
Who can join
Adults 18 to 40, any sex, with Plaque Accumulation or Patient Acceptance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Mouthrinses are recommended as a complement to mechanical methods in oral hygiene procedures to prevent and control periodontal diseases. Chlorhexidine mouthrinse has been used as a chemical plaque control agent for many years. However, in spite of its potent antimicrobial and antiplaque properties, there have been various reports of the undesirable adverse effects of chlorhexidine mouthrinse. This creates the need to look for an alternative mouthrinse that can also help in controlling plaque. Stingless bee honey is an alternative agent which is increasingly known for its better properties and easily available compared to other types of honey. It has been reported to have many benefits for the oral cavity such as antibacterial, anti-inflammatory, and healing properties which makes it a potential therapeutic agent in periodontal therapy. However, there is a lack of clinical studies showing its efficacy in plaque control as a mouthrinse. Hence, this study aims to investigate the ability of stingless bee honey mouthrinse to reduce plaque accumulation. This will be done through a randomised clinical trial whereby subjects will be prescribed with a mouthrinse formulation and instructed to refrain from any tooth cleaning procedure. The patient's plaque score will be recorded before and after the intervention to measure the effectiveness of the mouthrinse.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effects of a Stingless Bee Honey Mouth Rinse on Dental Plaque Accumulation: A Randomised Clinical Trial.
Reduan MH, Zulkaflee NS, Sabarudin MA, Mat Baharin NH, et al · · 2025 · PMID 40688909 · DOI 10.7759/cureus.86307 -
The Effect of Stingless Bee Honey Mouthrinse on Dental Plaque Accumulation: A Randomised Clinical Trial
Hayei NAA, Reduan MH, Zulkaflee NS, Baharin NHM, et al · · 2024 · DOI 10.21203/rs.3.rs-4649855/v1
Verify or expand the search:
- PubMed search for NCT06223243
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Universiti Sains Islam Malaysia trials
Trials by the same sponsor.
- NCT04410159 — Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06223243 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universiti Sains Islam Malaysia
- Last refreshed: 25 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06223243.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing